SurVis Surgical AI Program (Hys / Pel)

Organization
Jmees Inc. · Japan
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

Jmees Inc. is a medical AI company located in Kashiwa, Chiba, Japan. It develops AI programs that support organ recognition during surgery, aiming to improve safety in operating rooms where surgeons rely on tacit knowledge of anatomy.

SurVis is a family of endoscopic surgery support programs. The AI analyzes the endoscopic video during an operation and highlights important anatomical structures on the monitor to support the surgeon's recognition of organs. Two products are listed: SurVis-Hys for total hysterectomy and SurVis-Pel for pelvic and lateral lymph node dissection. The company also offers Nurscope Connect, a smartphone app and viewer that supports bowel preparation before colonoscopy.

2. Highlighted features & specifications

  • SurVis-Hys: Endoscopic surgery support program for total hysterectomy.
  • SurVis-Pel: Support program for pelvic and lateral lymph node dissection, announced as approved in March 2026.
  • Organ recognition support: AI analyzes surgical video and emphasizes important structures on screen.
  • Clinical co-development: Developed together with the National Cancer Center Hospital East.
  • Nurscope Connect: Smartphone app and viewer for bowel preparation assessment before colonoscopy.

3. Potential application

Gynecologic and colorectal cancer surgery units in large hospitals could use the programs as a second pair of eyes during laparoscopic operations. Training hospitals could use the highlighted structures to teach residents. Endoscopy centers could use Nurscope Connect to check bowel preparation quality.

4. Benefits

Highlights key anatomical structures on the monitor during endoscopic surgery. Supports less experienced surgeons by making expert judgment more visible. Aims to reduce surgeon burden and improve surgical safety. Backed by a validation study with 36 surgeons for the pelvic lymph node dissection AI.

6. Other information

Based in Kashiwa, Chiba, Japan. SurVis-Pel co-developed with the National Cancer Center Hospital East; SurVis-Hys sales began in July 2025; adopted into an AMED medical-engineering global expansion program (August 2025); won first place in two MICCAI tasks in two consecutive years.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us